NCT04891042 (Isthmocele) is a clinical trial in Uterus; Scar, sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital.

Who is sponsoring NCT04891042?

NCT04891042 is sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital.

What condition does NCT04891042 study?

NCT04891042 studies Uterus; Scar.

Is NCT04891042 still recruiting?

NCT04891042 is currently status unknown. Last updated 18 May 2021.

Last reviewed 2021-05-18 · How we verify

NCT04891042: Isthmocele

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Isthmocele Development Due to Primary Cesarean Section at The Latent or Active Phase

Status unknown Last updated 18 May 2021

What this trial tests

trial in Uterus; Scar in 320 participants. Status unknown.

Timeline

1 February 2021

Primary endpoint
2 May 2021

2 December 2021

Quick facts

Lead sponsor	Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	320
Start date	1 February 2021
Primary completion	2 May 2021
Estimated completion	2 December 2021
Sites	1 location across Turkey (Türkiye)

Conditions studied

Uterus; Scar — all drugs for Uterus; Scar →

Sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Who can join

Adults 18 to 45, female only, with Uterus; Scar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The importance of isthmocele development due to primary cesarean section at the latent or active phase of labour

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Uterus; Scar

Currently open trials in the same condition.

NCT06308172 — Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial · NA · recruiting

Other Zeynep Kamil Maternity and Pediatric Research and Training Hospital trials

Trials by the same sponsor.

NCT05786352 — Outcomes of Enhanced Recovery After Cesarean (ERAC) Protocol · NA · unknown
NCT07312617 — Short-Term Outcomes of TOT, TVT, and Burch Surgery Assessed by Transperineal Ultrasound · NA · completed
NCT05558046 — Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique · unknown
NCT05558852 — Laparoscopic Central and Anterior Compartment Prolapse Surgery: A Meshless Sacrocolpopexy Technique · NA · unknown
NCT04888091 — Comparison of the Effect of Cervical Mucus Cleaning Method Applied Before Embryo Transfer on Pregnancy Rates. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04891042 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Last refreshed: 18 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04891042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing